US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 0.820
  • -0.037-4.35%
Close Mar 28 16:00 ET
  • 0.820
  • 0.0000.00%
Post 19:55 ET
184.26MMarket Cap-1.67P/E (TTM)

About Sangamo Therapeutics Company

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.

Company Profile

SymbolSGMO
Company NameSangamo Therapeutics
Listing DateApr 6, 2000
Issue Price15.00
Founded1995
CEODr. Alexander Donald Macrae, M.B.,PhD
MarketNASDAQ
Employees183
Fiscal Year Ends12-31
Address501 Canal Boulevard
CityRichmond
ProvinceCalifornia
CountryUnited States of America
Zip Code94084
Phone1-510-970-6000
Websitehttp://www.sangamo.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Alexander Donald Macrae, M.B.,PhD
  • Director, President and Chief Executive Officer
  • 2.39M
  • Nathalie Dubois-Stringfellow, PhD
  • Senior Vice President and Chief Development Officer
  • 1.03M
  • Prathyusha Duraibabu
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 1.06M
  • Amy Pooler, PhD
  • Vice President and Head of Research
  • --
  • Scott B. Willoughby
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Margaret A. Horn, J.D.
  • Independent Director
  • 71.25K
  • Courtney Beers
  • Independent Director
  • 73.24K
  • Robert F. Carey
  • Independent Director
  • 80.53K
  • James R. Meyers
  • Independent Director
  • 78.66K
  • Dr. Kenneth J. Hillan, Ch.B.,M.B.
  • Independent Director
  • 71.16K
  • Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
  • Independent Director
  • 76.78K
  • Dr. John H. Markels, PhD
  • Independent Director
  • 76.78K
  • H. Stewart Parker
  • Chairwoman of the Board
  • 99.28K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Symbol Mini Chart % Chg
The Kroger Co.
KR
+0.88%
The Kraft Heinz
KHC
+0.57%
Chevron
CVX
-0.34%
Coca-Cola
KO
-0.52%
Chubb Ltd
CB
-0.64%

Unlock the Full List

Investment Theme Gene Editing
Gene Editing
Intraday-1.92%